ABSTRACT
The disease has a poor prognosis, and most women who develop ovarian cancer die from the disease within five years of diagnosis. Despite research efforts to develop a screening test for early detection of ovarian cancers, no test has yet been shown to reduce the mortality from ovarian cancer. However, research studies of proteomics (biological markers found in the blood) might hold promise for the future.
